The Evaluation of Acetaminophen Use for Adult Patients at Community Pharmacies in Korea

지역약국 방문 성인 환자의 Acetaminophen 사용 현황 평가

  • Lee, Yu-Jeung (Graduate School of Clinical Pharmacy, Sookmyung Women's University)
  • 이유정 (숙명여자대학교 임상약학대학원)
  • Received : 2010.01.31
  • Accepted : 2010.04.22
  • Published : 2010.06.30

Abstract

Acetaminophen is one of the most commonly used over-the-counter medication in Korea. It is a safe and effective medication for the treatment of mild to moderate pain or fever when used in therapeutic doses. However, acetaminophen overdose is a frequent cause of acute liver failure. The purpose of this study was to evaluate the acetaminophen use for adult patients at community pharmacies in Korea. This study was a 11-questionnaire survey conducted from December 15, 2009 to January 5, 2010. Of the 204 respondents, 117 (57.4%) had used acetaminophen products within 6 months. Only 20 (9.8%) reported having knowledge about the daily maximum doses of acetaminophen, and 3 out of 20 knew it correctly. Only 10 (4.9%) reported having knowledge about the potentialtoxicity of acetaminophen overdose, and 7 out of 10 knew that acetaminophen overdose could cause liver toxicity. The results of this study indicates a need for pharmacists to educate patients regarding the appropriate doses and potential toxicities of acetaminophen.

Keywords

References

  1. Shimp, L. A. : Safety issues in the pharmacologic management of chronic pain in the elderly. Pharmacotherapy 18, 1313 (1998).
  2. Schnitzer, T. J. : Non-NSAID pharmacologic treatment options for the management of chronic pain. Am. J. Med. 105(1B), 45S (1998). https://doi.org/10.1016/S0002-9343(98)00073-4
  3. Editorial Staff : AHFS Drug Information 2006., American Society of Health-System Pharmacists, Bethesda, Maryland, p. 2152 (2006).
  4. Lee, W. M. : Drug-induced hepatotoxicity. N. Engl. J. Med. 349, 474 (2003). https://doi.org/10.1056/NEJMra021844
  5. Whitcomb, D. C. and Block, G. D. : Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 272, 1845 (1994). https://doi.org/10.1001/jama.272.23.1845
  6. Forrest, J. A., Clements, J. A. and Prescott, L. F. : Clinical pharmacokinetics of paracetamol. Clin. Pharmacokinet. 7, 93 (1982). https://doi.org/10.2165/00003088-198207020-00001
  7. Bessems, J. G. and Vermeulen, N. P. : Paracetamol(acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit. Rev. Toxicol. 31, 55 (2001). https://doi.org/10.1080/20014091111677
  8. Ostapowicz, G., Fontana, R. J., Schiodt, F. V., Larson, A., Davern, T. J., Han, S. H., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., Crippin, J. S., Blei, A. T., Samuel, G., Reisch, J. and Lee, W. M. : Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann. Intern. Med. 137, 947 (2002). https://doi.org/10.7326/0003-4819-137-12-200212170-00007
  9. U.S. Food and Drug Administration. FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers to Help Consumers Use Products Safely. 4/28/2009. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149573.htm (accessed on January 17, 2010).
  10. Cham, E., Hall, L., Ernst, A. A. and Weiss, S. J. : Awareness and use of over-the-counter pain medications: a survey of emergency department patients. South. Med. J. 95, 529 (2002). https://doi.org/10.1097/00007611-200295050-00014